1. Home
  2. NVO vs V Comparison

NVO vs V Comparison

Compare NVO & V Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVO
  • V
  • Stock Information
  • Founded
  • NVO 1923
  • V 1958
  • Country
  • NVO Denmark
  • V United States
  • Employees
  • NVO N/A
  • V N/A
  • Industry
  • NVO Biotechnology: Biological Products (No Diagnostic Substances)
  • V Business Services
  • Sector
  • NVO Health Care
  • V Consumer Discretionary
  • Exchange
  • NVO Nasdaq
  • V Nasdaq
  • Market Cap
  • NVO 278.0B
  • V 671.5B
  • IPO Year
  • NVO N/A
  • V 2008
  • Fundamental
  • Price
  • NVO $69.81
  • V $354.38
  • Analyst Decision
  • NVO Buy
  • V Strong Buy
  • Analyst Count
  • NVO 3
  • V 28
  • Target Price
  • NVO $112.00
  • V $373.50
  • AVG Volume (30 Days)
  • NVO 8.8M
  • V 7.7M
  • Earning Date
  • NVO 08-06-2025
  • V 07-22-2025
  • Dividend Yield
  • NVO 1.69%
  • V 0.67%
  • EPS Growth
  • NVO 17.93
  • V 11.36
  • EPS
  • NVO 3.40
  • V 9.96
  • Revenue
  • NVO $43,922,211,349.00
  • V $37,621,000,000.00
  • Revenue This Year
  • NVO $18.59
  • V $12.19
  • Revenue Next Year
  • NVO $15.61
  • V $10.36
  • P/E Ratio
  • NVO $20.52
  • V $35.58
  • Revenue Growth
  • NVO 24.11
  • V 10.19
  • 52 Week Low
  • NVO $57.00
  • V $252.70
  • 52 Week High
  • NVO $143.69
  • V $375.51
  • Technical
  • Relative Strength Index (RSI)
  • NVO 46.24
  • V 50.10
  • Support Level
  • NVO $68.12
  • V $342.03
  • Resistance Level
  • NVO $70.42
  • V $357.00
  • Average True Range (ATR)
  • NVO 1.50
  • V 7.94
  • MACD
  • NVO -0.83
  • V -0.22
  • Stochastic Oscillator
  • NVO 20.18
  • V 49.58

About NVO Novo Nordisk A/S

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

About V Visa Inc.

Visa is the largest payment processor in the world. In fiscal 2024, it processed almost $16 trillion in total volume. Visa operates in over 200 countries and processes transactions in over 160 currencies. Its systems are capable of processing over 65,000 transactions per second.

Share on Social Networks: